Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Generic Retrovir Capsule Formulation Clears FDA

This article was originally published in The Pink Sheet Daily

Executive Summary

Approval of Aurobindo's zidovudine marks the first generic HIV/AIDS drug in capsule form in the U.S.

You may also be interested in...



GSK Retrovir Goes Generic

Zidovudine ANDAs from Ranbaxy, Roxane and Aurobindo are the first generic pediatric AIDS drugs approved for the U.S. market.

Metsera Launches As New Obesity Contender Flush With $290m

Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture. 

Teva Says The Time Is Right For Two Big Immunology Biosimilar Launches

US market access senior VP Tom Rainey talks to Scrip about the upcoming launches of biosimilar versions of Humira and Stelara.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS063942

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel